Monoclonal antibodies in detection of choroidal melanoma

Peter J. Ringens(Rotterdam University of Applied Sciences), A. W. M. van der Kamp(The Netherlands Cancer Institute), Sjoerd G. van Duinen(Leiden University Medical Center), Paulus T.V.M. de Jong(Leiden University), C. Vennegoor(The Netherlands Cancer Institute), Rien van Haperen(The Netherlands Cancer Institute), D. J. Ruiter(Radboud University Nijmegen)
Graefe s Archive for Clinical and Experimental Ophthalmology
May 1, 1989
10.1007/bf02172764
Cited by 8

Related Papers

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
|Molecular and Cellular Biology|1989|280
Aneurysmal bone cysts.A clinicopathological study of 105 cases
|Cancer|1977|269
c‐myc down‐regulates class I HLA expression in human melanomas.
|The EMBO Journal|1988|257
Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
|Journal of Clinical Oncology|1998|246
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240